Are you searching for effective medications to treat 'Alpha-1 Antitrypsin Deficiency'? This comprehensive guide provides the latest information on medications-both generic and branded-that are ...

Caption Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder associated with liver disease, ranging from fibrosis to hepatocellular carcinoma. The disease remains asymptomatic until its ...

The biotech company tested its experimental treatment in patients with alpha-1 antitrypsin deficiency. In this condition, the liver doesn't make enough — or any — of the AAT protein.

its gene editing candidate targeted at alpha-1 antitrypsin deficiency. With BEAM shares underperforming the broader biotech ...

A slew of pharma mergers and acquisitions in the first month of 2024 has continued with a $2.2 billion play by Sanofi for Inhibrx and its clinical-stage drug candidate for alpha-1 antitrypsin ...

Narrator Then there's a particularly lethal mix: a genetic, or hereditary predisposition due to alpha 1 antitrypsin deficiency. Diane Kay, COPD Patient I was diagnosed with alpha 1 in '99 but I ...

alpha-1 AT = alpha-1 antitrypsin; ANA = antinuclear antibodies; SMA = smooth muscle antibodies; anti-LKM1 = antibodies to liver/kidney microsome type 1; AMA = antimitochondrial antibodies ...

In our in vivo portfolio, the BEAM-302 clinical program in alpha-1 antitrypsin deficiency is expanding globally, with dosing complete for the first cohort of patients and data anticipated in 2025 ...